Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the full study content with a minimal page that includes a Home link and a revision note.
    Difference
    19%
    Check dated 2026-09-20T19:38:46.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Added Melanoma and related topics (MedlinePlus Genetics) to the page’s related topics, and updated the revision indicator from v3.6.5 to v3.6.6. These changes serve metadata/navigation purposes rather than altering the study details.
    Difference
    0.2%
    Check dated 2026-08-30T22:25:38.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now lacks the Melanoma label and related-topic links, indicating a pruning of topic signals and external resource references within the study details.
    Difference
    0.2%
    Check dated 2026-08-23T21:48:19.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the page, signaling a small metadata/format update.
    Difference
    0.1%
    Check dated 2026-08-09T11:08:17.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Melanoma is added as a topic, and MedlinePlus Genetics is listed as a related resource. The page revision was updated from v3.6.3 to v3.6.4.
    Difference
    0.2%
    Check dated 2026-07-25T18:11:13.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The related topics section was trimmed by removing Melanoma and MedlinePlus Genetics entries. This reduces the external resources shown alongside the study details.
    Difference
    0.2%
    Check dated 2026-07-11T13:09:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.